PH31680A - Genomic dna sequences encoding human bssl/cel. - Google Patents

Genomic dna sequences encoding human bssl/cel.

Info

Publication number
PH31680A
PH31680A PH46323A PH46323A PH31680A PH 31680 A PH31680 A PH 31680A PH 46323 A PH46323 A PH 46323A PH 46323 A PH46323 A PH 46323A PH 31680 A PH31680 A PH 31680A
Authority
PH
Philippines
Prior art keywords
cel
genomic dna
dna sequences
sequences encoding
encoding human
Prior art date
Application number
PH46323A
Other languages
English (en)
Inventor
Karl G Bjursell
Peter N I Carlsson
Ulf F P Lidberg
Jeanette A Nilsson
Curt S M Enerback
Stig L Hansson
Jan B F Tornell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9201809A external-priority patent/SE9201809D0/xx
Priority claimed from SE9201826A external-priority patent/SE9201826D0/xx
Priority claimed from SE9202088A external-priority patent/SE9202088D0/xx
Priority claimed from SE9300902A external-priority patent/SE9300902D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH31680A publication Critical patent/PH31680A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PH46323A 1992-06-11 1993-06-09 Genomic dna sequences encoding human bssl/cel. PH31680A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9201809A SE9201809D0 (sv) 1992-06-11 1992-06-11 New dna sequences
SE9201826A SE9201826D0 (sv) 1992-06-12 1992-06-12 New dna sequences ii
SE9202088A SE9202088D0 (sv) 1992-07-03 1992-07-03 New dna sequences iii
SE9300902A SE9300902D0 (sv) 1993-03-19 1993-03-19 New dna sequences iv

Publications (1)

Publication Number Publication Date
PH31680A true PH31680A (en) 1999-01-18

Family

ID=27484751

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46323A PH31680A (en) 1992-06-11 1993-06-09 Genomic dna sequences encoding human bssl/cel.

Country Status (31)

Country Link
US (2) US5616483A (fr)
EP (1) EP0651793B1 (fr)
JP (1) JP4231105B2 (fr)
KR (1) KR100357670B1 (fr)
CN (1) CN1071791C (fr)
AP (1) AP411A (fr)
AT (1) ATE447012T1 (fr)
AU (1) AU670598B2 (fr)
CA (1) CA2137815C (fr)
CZ (1) CZ288677B6 (fr)
DE (1) DE69334298D1 (fr)
DK (1) DK0651793T3 (fr)
ES (1) ES2335626T3 (fr)
FI (1) FI945793A7 (fr)
HR (1) HRP930935A2 (fr)
HU (1) HU220338B (fr)
IL (1) IL105874A (fr)
IS (1) IS4029A (fr)
MA (1) MA22905A1 (fr)
MX (1) MX9303439A (fr)
NO (1) NO944715L (fr)
NZ (1) NZ253391A (fr)
PH (1) PH31680A (fr)
PT (1) PT651793E (fr)
RU (1) RU2128708C1 (fr)
SG (1) SG52580A1 (fr)
SI (1) SI9300319A (fr)
SK (1) SK286993B6 (fr)
TN (1) TNSN93067A1 (fr)
UA (1) UA41322C2 (fr)
WO (1) WO1993025669A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692841B2 (en) * 1994-03-09 1998-06-18 Abbott Laboratories Transgenic animals producing oligosaccharides and glycoconjugates
US5907080A (en) * 1995-11-30 1999-05-25 Nexia Biotechnologies, Inc. Method for development of transgenic dwarf goats
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
US6395530B1 (en) * 1996-12-06 2002-05-28 Aventis Pharmaceuticals Inc. LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
FR2763958A1 (fr) * 1997-05-29 1998-12-04 Transgene Sa Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
SE9801424D0 (sv) * 1998-04-22 1998-04-22 Astra Ab Expression methods
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
WO2000061779A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 49 proteines humaines secretees
WO2001089553A1 (fr) * 1999-05-19 2001-11-29 Barnes Jewish Hospital Coefficient d'utilisation digestive de triglycerides ameliore dans une carence en sels biliaires
JP2004527210A (ja) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー 内皮細胞発現パターンの評価法
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US20030213007A1 (en) * 2002-03-27 2003-11-13 Slattery Charles Wilbur Human milk produced by human mammary tissue implanted in non-human host animals and uses thereof
US20060269552A1 (en) * 2003-06-09 2006-11-30 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
WO2007035870A2 (fr) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. Méthode pour analyser le lait
US20090228996A1 (en) * 2006-02-03 2009-09-10 William Anderson Paxton Means and Methods for influencing Interactions Between Dc-Sign and Dc-Sign Ligands
CA2706722C (fr) * 2006-11-29 2016-01-12 Prolacta Bioscience, Inc. Compositions de lait humain et procedes destines a fabriquer et utiliser ces compositions
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
US8246950B2 (en) 2007-02-20 2012-08-21 Aptalis Pharma Limited Stable digestive enzyme compositions
WO2009109856A2 (fr) 2008-03-07 2009-09-11 Axcan Pharma Inc. Procédé pour détecter un parvovirus infectieux dans des préparations pharmaceutiques
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
EP2629789A1 (fr) 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Procédé pour augmenter l'absorption d'acides gras insaturés par des nourrissons humains
WO2012052060A1 (fr) * 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Procédé pour augmenter la vitesse de croissance de nourrissons humains
CN103987265B (zh) 2011-08-03 2017-05-24 普罗莱克塔生物科学公司 减少细菌污染的人乳微滤
CA2843556A1 (fr) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Procede de test de dissolution de compositions solides contenant des enzymes digestives
CN103088000A (zh) * 2012-03-23 2013-05-08 北京济福霖生物技术有限公司 在哺乳动物乳腺中过表达胆盐激活脂酶的方法
RS54944B1 (sr) * 2012-07-12 2016-11-30 Proqr Therapeutics Ii Bv Oligonukleotidi za pravljenje promena u sekvencama ciljanih rnk molekula prisutnih u živoj ćeliji
FI3821713T3 (fi) 2013-03-13 2025-03-27 Prolacta Bioscience Inc Runsasrasvaisia äidinmaitotuotteita
MX2016001593A (es) 2013-08-09 2016-09-29 Allergan Pharmaceuticals Int Ltd Composicion de enzima digestiva adecuada para administracion enterica.
JP2017519490A (ja) 2014-06-19 2017-07-20 アプタリス ファルマ リミテッド 膵臓抽出物からのウイルス汚染の除去方法
AU2016381834B2 (en) 2015-12-30 2021-09-23 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
JP2022548785A (ja) 2019-09-24 2022-11-21 プロラクタ バイオサイエンス,インコーポレイテッド 炎症性疾患及び免疫疾患の治療のための組成物及び方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256150A (en) * 1964-04-20 1966-06-14 Dairyland Food Lab Method for treating malabsorption syndrome
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
SU1573026A1 (ru) * 1988-07-22 1990-06-23 Институт Биохимии И Физиологии Микроорганизмов Ан Ссср Рекомбинантна плазмидна ДНК pBG М3, определ юща синтез эндонуклеазы рестрикции С @ BI
US5173408A (en) * 1989-11-13 1992-12-22 Lange Louis George Iii Mammalian pancreatic cholesterol esterase
WO1991015534A1 (fr) * 1990-03-30 1991-10-17 Allied-Signal Inc. Poly(vinylenes aromatiques) et poly (vinylenes heteoaromatiques) electroconducteurs
SE9001985D0 (sv) * 1990-06-01 1990-06-01 Astra Ab New chemical products

Also Published As

Publication number Publication date
JPH07507687A (ja) 1995-08-31
DE69334298D1 (de) 2009-12-10
US5716817A (en) 1998-02-10
EP0651793B1 (fr) 2009-10-28
CA2137815C (fr) 2010-11-09
HU9403536D0 (en) 1995-02-28
SG52580A1 (en) 1998-09-28
MA22905A1 (fr) 1993-12-31
CN1086262A (zh) 1994-05-04
WO1993025669A1 (fr) 1993-12-23
RU94046360A (ru) 1997-06-10
AU4366793A (en) 1994-01-04
SK286993B6 (sk) 2009-09-07
ATE447012T1 (de) 2009-11-15
CZ288677B6 (cs) 2001-08-15
AU670598B2 (en) 1996-07-25
NZ253391A (en) 1996-01-26
KR100357670B1 (ko) 2003-04-11
FI945793L (fi) 1995-02-09
CZ309194A3 (en) 1995-07-12
IL105874A0 (en) 1993-10-20
IS4029A (is) 1993-12-12
CA2137815A1 (fr) 1993-12-23
RU2128708C1 (ru) 1999-04-10
SK148694A3 (en) 1995-08-09
UA41322C2 (uk) 2001-09-17
MX9303439A (es) 1994-04-29
HRP930935A2 (en) 1994-12-31
NO944715L (no) 1995-02-07
AP411A (en) 1995-09-28
CN1071791C (zh) 2001-09-26
DK0651793T3 (da) 2010-03-15
HUT71789A (en) 1996-02-28
JP4231105B2 (ja) 2009-02-25
NO944715D0 (no) 1994-12-07
HU220338B (hu) 2001-12-28
FI945793A7 (fi) 1995-02-09
TNSN93067A1 (fr) 1994-03-17
PT651793E (pt) 2010-01-20
IL105874A (en) 1998-12-27
ES2335626T3 (es) 2010-03-30
US5616483A (en) 1997-04-01
FI945793A0 (fi) 1994-12-09
SI9300319A (en) 1994-03-31
EP0651793A1 (fr) 1995-05-10
AP9300538A0 (en) 1993-07-31

Similar Documents

Publication Publication Date Title
PH31680A (en) Genomic dna sequences encoding human bssl/cel.
SG49117A1 (en) Alfa -1, 3-fucosyltransferase
GB9600384D0 (en) Dna glycosylases
AU7978694A (en) Catalytic dna
EP0634459A3 (fr) Formulations.
EP0654742A3 (fr) Interface de bus multiples.
IL98134A0 (en) Single chain t-receptors,nucleic acid sequences coding therefor and pharmaceutical compositions containing the same
GB9408717D0 (en) DNA sequences
GB9404590D0 (en) Multipurpose sickbed
EP0628291A3 (fr) Brosse à dents.
ZA973642B (en) DNA vaccine formulations.
ZA9710288B (en) Novel genes encoding telomerase proteins.
ZA972169B (en) Biodecontamination reactor.
EP0671470A3 (fr) Enzyme libérant du tréhalose, ADN codant pour cela, leur préparation et utilisation.
ZA961082B (en) DNA sequence.
EP0685557A4 (fr) Nouvelle metalloprotease et adn codant pour cette derniere.
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
GB9526218D0 (en) DNA Sequences
AU3651597A (en) Dna sequences encoding human tcak1 kinase
PL340374A1 (en) Tanatin encoding gene
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
EP0607005A3 (fr) ADN isolé encodant l'endonucléase de restriction Not I et procédés pour leur production.
IL112327A (en) Dna sequence encoding an organophosphate-resistant e3 esterase, an organophosphate-resistant e3 esterase encoded thereby and uses thereof
PH31659A (en) Therapeutic nucleotides.
GB9410170D0 (en) Nucleic acid